Updates in Structural Heart: Surgeons are Still in the Game

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Tsuyoshi Kaneko, MD
Disclosure(s): Abbott: Advisory Board (Ongoing); Edwards Lifesciences: Advisory Board (Ongoing), Consultant (Ongoing); Johnson and Johnson: Advisory Board (Ongoing); Medtronic, Inc.: Consultant (Ongoing)

Sara Pereira, MD
Disclosure(s): Edwards Lifesciences: Consultant (Ongoing), Speaker (Ongoing)

Presentations

  1. An Age-Based Analysis of Transcatheter and Surgical Outcomes in Low-Risk Patients Undergoing Aortic Valve Replacement for Aortic Valve Stenosis
    Tomaz Mesar, MD
     
  2. Sky Is Not the Limit for TAVR: Limitations of TAVR and Perfecting SAVR
    Karen M. Kim, MD
     
  3. Reintervention After TAVR: The Implications for Lifetime Management
    Marc P. Pelletier, MD, MSc, FRCSC
    Disclosure(s): Edwards Lifeciences: Consultant (Ongoing); Medtronic Inc: Consultant (Ongoing)
     
  4. Panel Discussion
     
  5. National Trends in Mitral Valve Surgery Outcomes in Centers with and Without Transcatheter Edge-to-Edge Repair
    Sophia Roberts Pyeatte, MD
     
  6. Lessons learned: How Can Surgeons be Actively Engaged in Transcatheter Tricuspid Procedures?
    Gilbert Tang, MD, MSc, MBA, FRCSC, FACC
    Disclosure(s): Boston Scientific: Advisory Board (Ongoing), Consultant (Ongoing); Edwards Lifesciences, Peija Medical, Shenqi Medical Technology: Consultant (Ongoing); Medtronic, Abbott Structural Heart: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
     
  7. TEER in DMR: Will Surgery Stand a Chance?
    Patrick M. McCarthy, MD
    Disclosure(s): Abbott Inc.: Speaker (Ongoing), Surgical PI Repair MR Study (Unfunded/Unpaid) (Ongoing); Arthrex: Consultant (Ongoing); Atricure: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Speaker (Ongoing)
     
  8. Panel Discussion
Activity summary
Available credit: 
  • 1.50 ABS Accredited CME
  • 1.50 ABTS Accredited CME
  • 1.50 AMA PRA Category 1 Credit™
Activity opens: 
03/01/2025
Activity expires: 
03/01/2028
Cost:
$0.00
Part of: 
2025 STS Annual Meeting Online: Adult Cardiac Track
Rating: 
0

Available Credit

  • 1.50 ABS Accredited CME
  • 1.50 ABTS Accredited CME
  • 1.50 AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Tsuyoshi Kaneko, MD
Disclosure(s): Abbott: Advisory Board (Ongoing); Edwards Lifesciences: Advisory Board (Ongoing), Consultant (Ongoing); Johnson and Johnson: Advisory Board (Ongoing); Medtronic, Inc.: Consultant (Ongoing)

Sara Pereira, MD
Disclosure(s): Edwards Lifesciences: Consultant (Ongoing), Speaker (Ongoing)

Presentations

  1. An Age-Based Analysis of Transcatheter and Surgical Outcomes in Low-Risk Patients Undergoing Aortic Valve Replacement for Aortic Valve Stenosis
    Tomaz Mesar, MD
     
  2. Sky Is Not the Limit for TAVR: Limitations of TAVR and Perfecting SAVR
    Karen M. Kim, MD
     
  3. Reintervention After TAVR: The Implications for Lifetime Management
    Marc P. Pelletier, MD, MSc, FRCSC
    Disclosure(s): Edwards Lifeciences: Consultant (Ongoing); Medtronic Inc: Consultant (Ongoing)
     
  4. Panel Discussion
     
  5. National Trends in Mitral Valve Surgery Outcomes in Centers with and Without Transcatheter Edge-to-Edge Repair
    Sophia Roberts Pyeatte, MD
     
  6. Lessons learned: How Can Surgeons be Actively Engaged in Transcatheter Tricuspid Procedures?
    Gilbert Tang, MD, MSc, MBA, FRCSC, FACC
    Disclosure(s): Boston Scientific: Advisory Board (Ongoing), Consultant (Ongoing); Edwards Lifesciences, Peija Medical, Shenqi Medical Technology: Consultant (Ongoing); Medtronic, Abbott Structural Heart: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
     
  7. TEER in DMR: Will Surgery Stand a Chance?
    Patrick M. McCarthy, MD
    Disclosure(s): Abbott Inc.: Speaker (Ongoing), Surgical PI Repair MR Study (Unfunded/Unpaid) (Ongoing); Arthrex: Consultant (Ongoing); Atricure: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Speaker (Ongoing)
     
  8. Panel Discussion